SYMYOO, a full service CRO and digital healthcare technology company, has officially announced the launch of Phase 1 of its SYNeRA™️ Clinical Trial Management System (CTMS). This release marks a significant step toward streamlining clinical trial operations and ensuring high-quality data through an integrated digital solution, setting a new standard for clinical trial digitization.
All-in-one, Completely Integrated Trial Management System
SYNeRA™️ CTMS Phase 1 is equipped with core functions for clinical trial operation management and electronic case report form (eCRF) functionality, which is the center of the clinical trial, enabling integrated management of the entire process from subject registration to data collection and clinical operation into a single system. Through an intuitive interface, users can efficiently input and manage data and systematically manage data quality through real-time data monitoring.
The Phase 1 release includes following core functions for clinical trial operations:
￭ Randomization: Flexible randomization tools tailored to various clinical study designs, minimizing bias and ensuring scientific rigor
￭ Data Management: Complete support for data entry, cleaning, query resolution, and validation to uphold data quality standards
￭ Investigational Product Supply Management: Real-time tracking and management of drug inventory, shipments, and usage across sites
￭ Site Management: Centralized management of site information, documentation, contracts, and personnel for improved coordination
￭ Site Data Oversight: Dashboards and tools for monitoring key site metrics such as enrollment rates, dropouts, and monitoring activities—enabling real-time, data-driven decision making
￭ Project Management: Tools for managing timelines, milestones, budgets, and tasks across trial phases to ensure operational control
￭ User Access Management: Role-based access control (RBAC) ensures secure and scalable system use across various teams and roles
Building a Fully Integrated Clinical Trial Ecosystem
With the launch of Phase 1, SYMYOO is laying the foundation for a fully integrated CTMS platform that will continue to evolve. Upcoming phases will introduce advanced features such as automated monitoring, Risk-Based Quality Management (RBQM), and smart reporting capabilities.
A SYMYOO representative stated, “Phase 1 of our CTMS is more than just a data management tool—it’s a foundation for managing clinical trials in a data-driven, integrated manner. We’re committed to developing solutions that meet the real-world needs of clinical trial professionals and support faster, safer drug development.”